UBS Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
Go back to UBS Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 25.49 -0.01 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.50 | 52 Week High | $42.49 | |||
| Open | $25.58 | 52 Week Low | $16.64 | |||
| Day High | $25.64 | P/E | N/A | |||
| Day Low | $24.95 | EPS | $-0.42 | |||
| Volume | 1,221,007 | |||||
